Bentham Science Logo

Track Your Manuscript:


Current Vascular Pharmacology

Volume 20, 6 Issues, 2022
ISSN: 1875-6212 (Online)
ISSN: 1570-1611 (Print)
This journal supports open access

Aims & Scope

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Editor-in-Chief

Dimitri P. Mikhailidis
(38,395 citations; H-index 89 citations)
Honorary Professor, Division of Surgery and Interventional Science
University College London Medical School, University College
Royal Free Hospital Campus
London (UCL) and former Academic Head, Department of Clinical
Biochemistry, Royal Free Hospital Campus (UCL), Pond Street
London, NW3 2QG
(UK)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Vascular Pharmacology Journal was launched in 2003. Dr. Dimitri P. Mikhailidis serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog